Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01561118
Other study ID # Uni-Koeln-1137
Secondary ID DFG HO 1272/21-1
Status Completed
Phase N/A
First received March 20, 2012
Last updated November 6, 2017
Start date September 2012
Est. completion date October 2017

Study information

Verified date November 2017
Source University Hospital, Bonn
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Physical activity is considered essential for optimal health, development, socialization and well-being of children. However patients with end-stage renal disease (ESRD) are often restricted from participation in exercise activities. This is especially true for children on hemodialysis (HD). As a consequence their exercise capacity is reduced, both before, but most impressively after HD. In a nationwide randomized, multi-center design this study aims to proof the influence of an individualised endurance training program by bicycle ergometer performed during dialysis on the efficacy of HD, measured as single pool Kt/V. Secondary goals are to enhance physical performance, physical and mental well-being, and to improve measurable blood and treatment parameters (e.g. haemoglobin level, amount of medication). A positive impact of physical activity was observed in adults on HD, although most studies did not address this issue in a randomised protocol. Despite this beneficial evidence in adults, sport is still not integrated as part of standard care in patients on maintenance HD. The study protocol, developed in close collaboration with the German Sport University Cologne, differs substantially from previously published reports as it uses bicycle ergometer training in an upright position outside the dialysis couch and adapts the intensity of intervention to the patient's capabilities. Based on the expected results the investigators will develop an individualised training program to be integrated in the standard care of (pediatric) patients on maintenance HD.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date October 2017
Est. primary completion date October 2017
Accepts healthy volunteers No
Gender All
Age group 6 Years to 19 Years
Eligibility Inclusion Criteria:

- End stage renal disease with need of renal replacement therapy

- children and adolescents aged =6 to =19 years

- maintenance hemodialysis for at least 3 months

- Stable and appropriate dialysis condition in the last 4 weeks before inclusion to the study (basically stable blood and dialysate flow rate and same dialyser)

- single pool Kt/V according to Dialysestandard 2006 > 1.2

- Informed consent

Exclusion Criteria:

- Participation in another interventional clinical trial

- severe primary neurologic, orthopaedic or cardiac disease, or secondary disease known as a contraindication for endurance training

- uncontrolled hyper- or hypotension, or cardiac disease

- Recurrent uncontrolled epileptic seizures

- dialysis shunt at the lower limbs

- pregnancy

- already planned medical intervention, for example living donor kidney transplantation or any other surgery, within the first period of the trial which will cause cancelation of more then 3 training units in a row

- Subjects who are in dependency to the sponsor or the PI of the trial, or confined to an institution on judicial or official behalf

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Bicycle-Ergometer Training
Performance adapted, hence individualised three times weekly bicycle-ergometer training during hemodialysis. Each training will last 30 to 50 minutes with 70-80% of the patient specific maximum workload over 12 weeks (36 training sessions - first part of the study compared to no intervention). In the second part of the study both groups get the opportunity for another 12 weeks of individualised three times weekly bicycle-ergometer training during hemodialysis.

Locations

Country Name City State
Germany University Hospital Bonn. Department of Pediatric and Adolescent Medicine, Division of Pediatric Nephrology Bonn

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Bonn German Sport University, Cologne

Country where clinical trial is conducted

Germany, 

References & Publications (2)

Hoppe B, Schaar B. The impact of nutrition and physical activity on long-term survival after pediatric solid organ transplantation. Pediatr Transplant. 2012 Nov;16(7):675-7. doi: 10.1111/j.1399-3046.2012.01663.x. Epub 2012 Feb 21. — View Citation

Schaar B, Feldkötter M, Nonn JM, Hoppe B. Cardiorespiratory capacity in children and adolescents on maintenance haemodialysis. Nephrol Dial Transplant. 2011 Nov;26(11):3701-8. doi: 10.1093/ndt/gfr014. Epub 2011 Mar 4. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change of single pool Kt/V (KDOQI Guidelines) - expressed as the change of single pool Kt/V from week 0 to 12 of intervention (period 1) Change of single pool Kt/V (spKt/V) measured at week 12 (V1) compared to baseline (V0). Single pool Kt/V is the standard measure to assess dialysis efficacy. As dialysis efficacy is the primary aim of dialysis treatment and the spKt/V is the best way to measure efficacy this figure has an important clinical relevance for the patient. 12 weeks
Secondary Change of the possible workload (maximum physical performance) achieved The maximal possible workload will be determined by an exercise evaluation program with increasing power on a leg bicycle ergometer before a hemodialysis session, measuring the peak oxygen uptake (VO2-peak), heart rate, blood pressure and lactate levels during exercise. 12 and 24 weeks
Secondary Quality of Life For quality of life assessment the validated and standardized PedsQL® questionnaires will be filled in by patients and parents. 12 and 24 weeks
Secondary Change of solute removal during hemodialysis Solute removal during hemodialysis has a clear impact on the patient's health and well-being, as it reduces sequelae and offers the patient less restrictions on their diet, which would lead to a better compliance. 12 and 24 weeks
Secondary Change of solute removal in the two compartment model (assessed in a subgroup of patients) Solute removal in the two compartment model will only be analyzed in patients 12 years of age or older with explicit consent to a second blood drawing 30 minutes after end of hemodialysis session. It was previously used showing a significant enhancement during exercise, explained by an increase of skeletal muscles perfusion during exercise. 12 and 24 weeks
Secondary Inflammation, nutritional status and bone metabolism The nutritional status and bone metabolism will be determined as they are important for optimal health and growth of paediatric hemodialysis patients. Evidence is based on studies that showed trends towards a better nutritional status and less chronic inflammation. 12 and 24 weeks
Secondary Body Composition Monitoring (BCM) Body Cpomposition Monitoring (BCM) will be performed to exermine further information on nutrional status, overhydration and muscle growth. 12 and 24 weeks
Secondary Change of number and dose of medication needed Number and dose of medication will be recorded, changes will be evaluated, and data will be correlated to e.g. the measured blood pressure (antihypertensive drugs) or haemoglobin levels (EPO or EPO stimulating agents). 12 and 24 weeks
Secondary Telomere length and Telomerase activity Telomere length and telomerase activity [units] will be used as markers for cell survival, which may be influenced by endurance training. 12 and 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT04103177 - Physical Activity in Haemodialysis Patients: a Feasibility Study N/A
Withdrawn NCT03645720 - The Prognosis of Graft Using Plastic Cannula in Hemodialysis N/A
Active, not recruiting NCT02598635 - Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis Phase 4
Terminated NCT01643733 - Study on Fistuloplasty Using Flow Measurement Guidance N/A
Not yet recruiting NCT03169400 - Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) N/A
Completed NCT02439697 - A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients N/A
Completed NCT02063490 - Nurse-led Intervention to Improve Phosphate Binder Adherence N/A
Completed NCT04106310 - Theranova vs High-flux HD Comparison N/A
Recruiting NCT06056102 - CAR-T Cell Therapy for Desensitization in Kidney Transplantation Phase 1
Completed NCT04698512 - MAgicTouch™ Intervention Leap for Dialysis Access (MATILDA) Trial
Completed NCT02819011 - OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO Phase 2
Completed NCT02484118 - Hemodialysis Blood Flow and Urea Clearance N/A
Enrolling by invitation NCT01641757 - Effect of Non-Surgical Periodontal Therapy on Serum Albumin Levels of Patients on Maintenance Hemodialysis Therapy, Phase 2
Completed NCT03172039 - Antimicrobial Use and Stewardship in an Outpatient Hemodialysis Unit N/A
Completed NCT03897231 - Prevalence of Non-adherence to Medication Among Patients on Chronic Hemodialysis
Withdrawn NCT03145662 - High Pressure Balloon vs Cutting Balloon N/A
Completed NCT02621918 - The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis N/A
Completed NCT01356615 - Low Molecular Weight Heparin for Hemodialysis Anticoagulation N/A
Terminated NCT01033357 - Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access N/A
Recruiting NCT05927532 - Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study N/A

External Links